American Journal of Roentgenology, Vol 166, 91-95, Copyright © 1996 by American Roentgen Ray Society

ARTICLES

Portal-phase contrast-enhanced helical CT for the detection of malignant hepatic tumors: sensitivity based on comparison with intraoperative and pathologic findings

BS Kuszyk, DA Bluemke, BA Urban, MA Choti, RH Hruban, JV Sitzmann and EK Fishman
Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins Medical Institutions, Baltimore, MD 21287, USA.

OBJECTIVE. The purpose of this study was to determine the sensitivity of portal-phase IV contrast-enhanced helical CT in detecting malignant hepatic tumors using a lesion-by-lesion comparison with surgical and pathologic findings. MATERIALS AND METHODS. Preoperative portal-phase contrast-enhanced helical CT studies in 21 patients (13 men, eight women) with malignant neoplasms of the liver (12 patients with primary hepatic tumors, nine patients with metastases) were reviewed retrospectively by three radiologists with the knowledge that hepatic malignancies were present in each case. Helical CT findings were compared with intraoperative findings by palpation (21 patients), sonography (15 patients), and the results of pathologic examination of resected specimens (10 patients) in a lesion-by-lesion manner. Sixty- four malignant nodules were identified in resected specimens or at surgery by palpation or intraoperative sonography. For each nodule identified by surgical or pathologic means, CT findings were reviewed for the presence of a lesion of similar size and location. RESULTS. The readers identified 52 of 64 nodules on helical CT scans for an overall sensitivity of 81%. Sixteen of 21 primary tumors (76%) and 36 of 43 metastatic tumors (84%) were identified on CT scans. The sensitivity was 91% for nodules greater than 1 cm (42 of 46) and 56% for nodules 1 cm or less (10 of 18). False-positive findings occurred in 4% of lesions seen on helical CT scans. CONCLUSION. Our results show that portal-phase contrast-enhanced helical CT is extremely sensitive (91%) for detecting malignant hepatic tumors greater than 1 cm, is relatively insensitive (56%) for tumors less than 1 cm, and has a low false- positive rate. These results compare favorably with published results for CT during arterial portography, the current gold standard for liver tumor detection, suggesting that portal-phase IV contrast-enhanced helical CT is an excellent noninvasive preoperative study prior to hepatic resection or cryosurgery.
CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				J. Ward, P. J. Robinson, J. A. Guthrie, S. Downing, D. Wilson, J. P. A. Lodge, K. R. Prasad, G. J. Toogood, and J. I. Wyatt Liver Metastases in Candidates for Hepatic Resection: Comparison of Helical CT and Gadolinium- and SPIO-enhanced MR Imaging Radiology, October 1, 2005; 237(1): 170 - 180. [Abstract] [Full Text] [PDF]

				S.M. M. de Castro, E.H. B. M. Tilleman, O.R. C. Busch, O.M. van Delden, J.S. Lameris, T.M. van Gulik, H. Obertop, and D.J. Gouma Diagnostic Laparoscopy for Primary and Secondary Liver Malignancies: Impact of Improved Imaging and Changed Criteria for Resection Ann. Surg. Oncol., May 1, 2004; 11(5): 522 - 529. [Abstract] [Full Text] [PDF]

				P. Soyer, M. Poccard, M. Boudiaf, M. Abitbol, L. Hamzi, Y. Panis, P. Valleur, and R. Rymer Detection of Hypovascular Hepatic Metastases at Triple-Phase Helical CT: Sensitivity of Phases and Comparison with Surgical and Histopathologic Findings Radiology, May 1, 2004; 231(2): 413 - 420. [Abstract] [Full Text] [PDF]

				I. R. Kamel, M. A. Choti, K. M. Horton, H. J. V. Braga, B. A. Birnbaum, E. K. Fishman, R. E. Thompson, and D. A. Bluemke Surgically Staged Focal Liver Lesions: Accuracy and Reproducibility of Dual-Phase Helical CT for Detection and Characterization Radiology, June 1, 2003; 227(3): 752 - 757. [Abstract] [Full Text] [PDF]

				M. A. Haider, M. M. Amitai, D. C. Rappaport, M. E. O'Malley, A. E. Hanbidge, M. Redston, G. A. Lockwood, and S. Gallinger Multi-Detector Row Helical CT in Preoperative Assessment of Small (<=1.5 cm) Liver Metastases: Is Thinner Collimation Better? Radiology, October 1, 2002; 225(1): 137 - 142. [Abstract] [Full Text] [PDF]

				W H Allum, S M Griffin, A Watson, and D Colin-Jones Guidelines for the management of oesophageal and gastric cancer Gut, June 1, 2002; 50 (2007): v1 - v23. [Full Text] [PDF]

				K. W. Kim, B. I. Choi, J. K. Han, T. K. Kim, A. Y. Kim, H. J. Lee, Y. H. Kim, J.-I. Choi, K.-H. Do, H. C. Kim, et al. Postoperative Anatomic and Pathologic Findings at CT Following Gastrectomy RadioGraphics, March 1, 2002; 22(2): 323 - 336. [Abstract] [Full Text] [PDF]

				G. N. Mann, H. F. Marx, L. L. Lai, and L. D. Wagman Clinical and Cost Effectiveness of a New Hepatocellular MRI Contrast Agent, Mangafodipir Trisodium, in the Preoperative Assessment of Liver Resectability Ann. Surg. Oncol., August 1, 2001; 8(7): 573 - 579. [Abstract] [Full Text] [PDF]

				C. Valls, E. Andía, A. Sánchez, A. Gumà, J. Figueras, J. Torras, and T. Serrano Hepatic Metastases from Colorectal Cancer: Preoperative Detection and Assessment of Resectability with Helical CT Radiology, January 1, 2001; 218(1): 55 - 60. [Abstract] [Full Text]

				D. A. Bluemke, E. K. Paulson, M. A. Choti, S. DeSena, and P. A. Clavien Detection of Hepatic Lesions in Candidates for Surgery: Comparison of Ferumoxides-Enhanced MR Imaging and Dual-Phase Helical CT Am. J. Roentgenol., December 1, 2000; 175(6): 1653 - 1658. [Abstract] [Full Text] [PDF]

				H.-J. Jang, J. H. Lim, S. J. Lee, C. K. Park, H. S. Park, and Y. S. Do Hepatocellular Carcinoma: Are Combined CT during Arterial Portography and CT Hepatic Arteriography in Addition to Triple-Phase Helical CT All Necessary for Preoperative Evaluation? Radiology, May 1, 2000; 215(2): 373 - 380. [Abstract] [Full Text]

				G. T. Sica, H. Ji, and P. R. Ros CT and MR Imaging of Hepatic Metastases Am. J. Roentgenol., March 1, 2000; 174(3): 691 - 698. [Full Text] [PDF]

				D. H. Sheafor, J. S. Killius, E. K. Paulson, D. M. DeLong, A. M. Foti, and R. C. Nelson Hepatic Parenchymal Enhancement during Triple-Phase Helical CT: Can It Be Used to Predict Which Patients with Breast Cancer Will Develop Hepatic Metastases? Radiology, March 1, 2000; 214(3): 875 - 880. [Abstract] [Full Text]

				K. M. Horton, R. A. Abrams, and E. K. Fishman Spiral CT of Colon Cancer: Imaging Features and Role in Management RadioGraphics, March 1, 2000; 20(2): 419 - 430. [Abstract] [Full Text] [PDF]

				B. S. Kuszyk, D. A. Bluemke, M. A. Choti, K. M. Horton, C. A. Magee, and E. K. Fishman Contrast-Enhanced CT of Small Hypovascular Hepatic Tumors: Effect of Lesion Enhancement on Conspicuity in Rabbits Am. J. Roentgenol., February 1, 2000; 174(2): 471 - 0. [Abstract] [Full Text] [PDF]

				S. Saini Imaging of the Hepatobiliary Tract N. Engl. J. Med., June 26, 1997; 336(26): 1889 - 1894. [Full Text] [PDF]